These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1378062

  • 1. Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.
    Müller F, Stiegler C, Hadding U.
    J Clin Microbiol; 1992 Jun; 30(6):1544-50. PubMed ID: 1378062
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM, Phelps CJ, Wilkins TD.
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [Abstract] [Full Text] [Related]

  • 3. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W, Liu WE, Li YM, Luo S, Zhong YM.
    Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
    Fu SW, Zhou DY, Lai ZS, Xue J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
    Koon HW, Shih DQ, Hing TC, Yoo JH, Ho S, Chen X, Kelly CP, Targan SR, Pothoulakis C.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
    [Abstract] [Full Text] [Related]

  • 9. Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays.
    Speirs JI, Akhtar M.
    Can J Microbiol; 1991 Aug; 37(8):650-3. PubMed ID: 1954579
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G, Muller MC, Wilkins TD, Lyerly D, L'Haridon R.
    Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
    [Abstract] [Full Text] [Related]

  • 16. New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.
    Genth H, Selzer J, Busch C, Dumbach J, Hofmann F, Aktories K, Just I.
    Infect Immun; 2000 Mar; 68(3):1094-101. PubMed ID: 10678912
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
    Hussack G, Arbabi-Ghahroudi M, van Faassen H, Songer JG, Ng KK, MacKenzie R, Tanha J.
    J Biol Chem; 2011 Mar 18; 286(11):8961-76. PubMed ID: 21216961
    [Abstract] [Full Text] [Related]

  • 20. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.
    Staneck JL, Weckbach LS, Allen SD, Siders JA, Gilligan PH, Coppitt G, Kraft JA, Willis DH.
    J Clin Microbiol; 1996 Nov 18; 34(11):2718-21. PubMed ID: 8897171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.